We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+7.35%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$4.21B
AUM Growth
+$306M
Cap. Flow
+$26.3M
Cap. Flow %
0.62%
Top 10 Hldgs %
29.48%
Holding
591
New
35
Increased
212
Reduced
160
Closed
13

Top Sells

Rank Stock Value
1
ASML icon
ASML
ASML
+$2.35M
2
TAIL icon
Cambria Tail Risk ETF
TAIL
+$2.23M
3
AAPL icon
Apple
AAPL
+$1.67M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.64M
5
MSFT icon
Microsoft
MSFT
+$1.59M

Sector Composition

Rank Sector Weight
1 Technology 20.06%
2 Healthcare 14.94%
3 Financials 12.73%
4 Communication Services 9.04%
5 Consumer Staples 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QYLD icon
151
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.06B
$3.28M 0.08%
146,426
-23,950
-14% -$536K
YUMC icon
152
Yum China
YUMC
$15.9B
$3.23M 0.08%
48,825
-140
-0.3% -$8.93K
VIXM icon
153
ProShares VIX Mid-Term Futures ETF
VIXM
$56.3M
$3.23M 0.08%
105,714
+22,266
+27% +$732K
PNC icon
154
PNC Financial Services
PNC
$99.2B
$3.16M 0.08%
16,563
+134
+0.8% +$25.1K
VEU icon
155
Vanguard FTSE All-World ex-US ETF
VEU
$66.8B
$3.09M 0.07%
48,722
-468
-1% -$29.6K
TSLA icon
156
Tesla
TSLA
$1.22T
$3.06M 0.07%
13,518
+588
+5% +$128K
MSCI icon
157
MSCI
MSCI
$41.9B
$3.01M 0.07%
5,652
-10
-0.2% -$4.77K
SPGI icon
158
S&P Global
SPGI
$122B
$2.96M 0.07%
7,221
+1,804
+33% +$693K
IJJ icon
159
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.85B
$2.93M 0.07%
27,778
FITB
160
Fifth Third Bancorp
FITB
$51.3B
$2.91M 0.07%
76,167
DVY icon
161
iShares Select Dividend ETF
DVY
$23.6B
$2.86M 0.07%
24,513
+1
+0% +$119
ITOT icon
162
iShares Core S&P Total US Stock Market ETF
ITOT
$93.8B
$2.82M 0.07%
28,551
+100
+0.4% +$9.62K
OXY icon
163
Occidental Petroleum
OXY
$55.6B
$2.73M 0.06%
87,277
-325
-0.4% -$8.72K
WSM icon
164
Williams-Sonoma
WSM
$27.5B
$2.7M 0.06%
33,810
-2,060
-6% -$175K
XYLD icon
165
Global X S&P 500 Covered Call ETF
XYLD
$3.22B
$2.65M 0.06%
54,149
+16,599
+44% +$801K
SYK icon
166
Stryker
SYK
$133B
$2.65M 0.06%
10,220
-11
-0.1% -$2.81K
CVS icon
167
CVS Health
CVS
$134B
$2.65M 0.06%
31,754
+1,813
+6% +$148K
CI icon
168
Cigna
CI
$76.1B
$2.65M 0.06%
11,172
CMI icon
169
Cummins
CMI
$87.3B
$2.52M 0.06%
10,324
+18
+0.2% +$4.6K
IWF icon
170
iShares Russell 1000 Growth ETF
IWF
$120B
$2.49M 0.06%
36,728
-500
-1% -$32.2K
NOC icon
171
Northrop Grumman
NOC
$76B
$2.47M 0.06%
6,793
+4
+0.1% +$1.44K
MDT icon
172
Medtronic
MDT
$110B
$2.43M 0.06%
19,554
+312
+2% +$39.2K
UPS icon
173
United Parcel Service
UPS
$89.5B
$2.28M 0.05%
10,979
+20
+0.2% +$4K
NFLX icon
174
Netflix
NFLX
$305B
$2.25M 0.05%
42,630
+8,170
+24% +$418K
AZN icon
175
AstraZeneca
AZN
$266B
$2.23M 0.05%
18,595
-1,125
-6% -$123K

Similar funds

Gofen & Glossberg's Q2 2021 Portfolio in Review

As of Q2 2021, Gofen & Glossberg held 591 positions worth $4.21B, up 7.8% from $3.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Gofen & Glossberg's Q2 2021 filing shows 35 new, 212 increased, 160 reduced and 13 closed positions. Its largest new stake was Organon & Co: 22,808 shares worth $690K. The largest sale was ASML, an estimated $2.35M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Gofen & Glossberg's largest Q2 2021 buy was Organon & Co: 22,808 shares worth $690K.
  • Gofen & Glossberg added most to Alcon in Q2 2021, an estimated $7.31M increase.
  • Gofen & Glossberg's biggest Q2 2021 reduction was ASML, cutting an estimated $2.35M.
  • Gofen & Glossberg fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $365K.
  • Gofen & Glossberg's ten largest holdings make up 29% of its $4.21B portfolio in Q2 2021.
  • Gofen & Glossberg opened 35 new positions and closed 13 in Q2 2021.
  • Gofen & Glossberg's portfolio value rose 7.8% quarter-over-quarter to $4.21B.

Based on Gofen & Glossberg's 13F filing for Q2 2021, filed 13 Jul 2021.